Article
Gut microbiome signatures linked to HIV-1 reservoir size and viremia control
11 Apr 2022
Abstract excerpt
BACKGROUND: The potential role of the gut microbiome as a predictor of immune-mediated HIV-1 control in the absence of antiretroviral therapy (ART) is still unknown. In the BCN02 clinical trial, which combined the MVA.HIVconsv immunogen with the latency-reversing agent romidepsin in early-ART treated HIV-1 infected individuals, 23% (3/13) of participants showed sustained low-levels of plasma viremia during 32...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
